Oct 3 (Reuters) - Dimension Therapeutics Inc  DMTX.O : 
    * Dimension Therapeutics says on termination of merger with 
Ultragenyx co will be required to pay Ultragenyx a termination 
fee of $2.9 million-SEC filing 
    * Dimension Therapeutics-co to reimburse Ultragenyx for $2.9 
million fee paid by Ultragenyx on behalf of dimension for 
termination of Regenxbio deal 
 
Source text: (http://bit.ly/2xZwnrr) 
Further company coverage:  DMTX.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))